{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:00:44Z","timestamp":1791450044303,"version":"4.3.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NCI","award":["1CA169175"],"award-info":[{"award-number":["1CA169175"]}]},{"DOI":"10.13039\/100001597","name":"Willard L. Eccles Charitable Foundation","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100001597","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Coit Family foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA046934"],"award-info":[{"award-number":["P30CA046934"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA69533"],"award-info":[{"award-number":["P30CA69533"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH-OD011092"],"award-info":[{"award-number":["NIH-OD011092"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01LM012877"],"award-info":[{"award-number":["K01LM012877"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002028","name":"Collins Medical Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Formalin-fixed, paraffin-embedded (FFPE) tissues for RNA-seq have advantages over fresh frozen tissue including abundance and availability, connection to rich clinical data, and association with patient outcomes. However, FFPE-derived RNA is highly degraded and chemically modified, which impacts its utility as a faithful source for biological inquiry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      True archival FFPE breast cancer cases (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200958), stored at room temperature for 2\u201323\u2009years, were utilized to identify key steps in tissue selection, RNA isolation, and library choice. Gene expression fidelity was evaluated by comparing FFPE data to public data obtained from fresh tissues, and by employing single-gene, gene set and transcription network-based regulon analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We report a single 10\u2009\u03bcm section of breast tissue yields sufficient RNA for RNA-seq, and a relationship between RNA quality and block age that was not linear. We find single-gene analysis is limiting with FFPE tissues, while targeted gene set approaches effectively distinguish ER+ from ER- breast cancers. Novel utilization of regulon analysis identified the transcription factor KDM4B to associate with ER+ disease, with KDM4B regulon activity and gene expression having prognostic significance in an independent cohort of ER+ cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results, which outline a robust FFPE-RNA-seq pipeline for broad use, support utilizing FFPE tissues to address key questions in the breast cancer field, including the delineation between indolent and life-threatening disease, biological stratification and molecular mechanisms of treatment resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-019-0643-z","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T10:04:38Z","timestamp":1576749878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["RNA-seq from archival FFPE breast cancer samples: molecular pathway fidelity and novel discovery"],"prefix":"10.1186","volume":"12","author":[{"given":"Nathan D.","family":"Pennock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duanchen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayasri","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne S.","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Searles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julja","family":"Burchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Weinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4244-987X","authenticated-orcid":false,"given":"Pepper","family":"Schedin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"643_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61\u201370.","journal-title":"Nature"},{"key":"643_CR2","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1210\/jc.2012-2423","volume":"97","author":"K Da Yu","year":"2012","unstructured":"Da Yu K, Wu J, Shen ZZ, Shao ZM. Hazard of breast cancer-specific mortality among women with estrogen receptor-positive breast cancer after five years from diagnosis: implication for extended endocrine therapy. J Clin Endocrinol Metab. 2012;97:2201\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"643_CR3","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.1158\/1078-0432.CCR-13-0838","volume":"19","author":"XHF Zhang","year":"2013","unstructured":"Zhang XHF, Giuliano M, Trivedi MV, Schiff R, Kent Osborne C. Metastasis dormancy in estrogen receptor-positive breast cancer. Clin Cancer Res. 2013;19:6389\u201397.","journal-title":"Clin Cancer Res"},{"key":"643_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr1399","volume":"8","author":"L Perreard","year":"2006","unstructured":"Perreard L, et al. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. Breast Cancer Res. 2006;8:1\u201311.","journal-title":"Breast Cancer Res"},{"key":"643_CR5","doi-asserted-by":"publisher","first-page":"e186997","DOI":"10.1001\/jamanetworkopen.2018.6997","volume":"2","author":"M Mori","year":"2019","unstructured":"Mori M, et al. Association between postpartum Breast Cancer diagnosis and metastasis and the clinical features underlying risk. JAMA Netw Open. 2019;2:e186997.","journal-title":"JAMA Netw Open"},{"key":"643_CR6","first-page":"9","volume":"393","author":"E Breast","year":"2019","unstructured":"Breast E, Trialists C, Group, C. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling : a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials. Lancet. 2019;393:9\u201311.","journal-title":"Lancet"},{"key":"643_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0001261","volume":"2","author":"S von Ahlfen","year":"2007","unstructured":"von Ahlfen S, Missel A, Bendrat K, Schlumpberger M. Determinants of RNA quality from FFPE samples. PLoS One. 2007;2:1\u20137.","journal-title":"PLoS One"},{"key":"643_CR8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.yexmp.2012.07.002","volume":"94","author":"D Groelz","year":"2013","unstructured":"Groelz D, et al. Non-formalin fixative versus formalin-fixed tissue: a comparison of histology and RNA quality. Exp Mol Pathol. 2013;94:188\u201394.","journal-title":"Exp Mol Pathol"},{"key":"643_CR9","first-page":"1","volume":"15","author":"W Zhao","year":"2014","unstructured":"Zhao W, et al. Comparison of RNA-Seq by poly (a) capture, ribosomal RNA depletion, and DNA microarray for expression profiling. BMC Genomics. 2014;15:1\u201311.","journal-title":"BMC Genomics"},{"key":"643_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1200\/po.17.00091","volume":"1","author":"J Li","year":"2018","unstructured":"Li J, Fu C, Speed TP, Wang W, Symmans WF. Accurate RNA Sequencing From Formalin-Fixed Cancer Tissue to Represent High-Quality Transcriptome From Frozen Tissue. JCO Precis Oncol. 2018;1:9. https:\/\/doi.org\/10.1200\/po.17.00091.","journal-title":"JCO Precis Oncol"},{"key":"643_CR11","doi-asserted-by":"publisher","unstructured":"Kwong LN, et al. Biological Validation of RNA Sequencing Data From Formalin-Fixed Paraffin-Embedded Primary Melanomas. JCO Precis Oncol. 2018:1\u201319. https:\/\/doi.org\/10.1200\/po.17.00259.","DOI":"10.1200\/po.17.00259"},{"key":"643_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nmeth.2483","volume":"10","author":"X Adiconis","year":"2013","unstructured":"Adiconis X, et al. Comparative analysis of RNA sequencing methods for degraded or low-input samples. Nat Methods. 2013;10:623\u20139.","journal-title":"Nat Methods"},{"key":"643_CR13","first-page":"1","volume":"2016","author":"Yan Guo","year":"2016","unstructured":"Guo Y, et al. RNA sequencing of formalin-fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining. Int J Genomics. 2016;2016:1\u201310.","journal-title":"International Journal of Genomics"},{"key":"643_CR14","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1056\/NEJMoa1510764","volume":"373","author":"JA Sparano","year":"2015","unstructured":"Sparano JA, et al. Prospective validation of a 21-gene expression assay in Breast Cancer. N Engl J Med. 2015;373:2005\u201314.","journal-title":"N Engl J Med"},{"key":"643_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/labinvest.3700529","volume":"87","author":"SK Penland","year":"2007","unstructured":"Penland SK, et al. RNA expression analysis of formalin-fixed paraffin-embedded tumors. Lab Investig. 2007;87:383\u201391.","journal-title":"Lab Investig"},{"key":"643_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-017-3867-3","volume":"18","author":"M Iddawela","year":"2017","unstructured":"Iddawela M, et al. Integrative analysis of copy number and gene expression in breast cancer using formalin-fixed paraffin-embedded core biopsy tissue: a feasibility study. BMC Genomics. 2017;18:1\u201313.","journal-title":"BMC Genomics"},{"key":"643_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jmoldx.2013.10.008","volume":"16","author":"A Sapino","year":"2014","unstructured":"Sapino A, et al. MammaPrint molecular diagnostics on formalin-fixed, paraffin-embedded tissue. J Mol Diagnostics. 2014;16:190\u20137.","journal-title":"J Mol Diagnostics"},{"issue":"4","key":"643_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/01495739808936707","volume":"1","author":"MARCUS G. PANDY","year":"1998","unstructured":"Illumina. Evaluating RNA Quality from FFPE Samples. Illumina Tech. 2016. https:\/\/doi.org\/10.1080\/01495739808936707 Note 1\u20134.","journal-title":"Computer Methods in Biomechanics and Biomedical Engineering"},{"key":"643_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10549-014-3019-2","volume":"146","author":"KE Varley","year":"2014","unstructured":"Varley KE, et al. Recurrent read-through fusion transcripts in breast cancer. Breast Cancer Res Treat. 2014;146:287\u201397.","journal-title":"Breast Cancer Res Treat"},{"key":"643_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"643_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1\u201321.","journal-title":"Genome Biol"},{"key":"643_CR22","unstructured":"Kolde R. Pheatmap: pretty heatmaps. R Packag Version. 2012;61:1\u20138."},{"key":"643_CR23","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"PS Bernard","year":"2009","unstructured":"Bernard PS, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009;27:1160\u20137.","journal-title":"J Clin Oncol"},{"key":"643_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/msb.2010.31","volume":"6","author":"C Lefebvre","year":"2010","unstructured":"Lefebvre C, et al. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers. Mol Syst Biol. 2010;6:1\u201310.","journal-title":"Mol Syst Biol"},{"key":"643_CR25","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ng.3593","volume":"48","author":"MJ Alvarez","year":"2016","unstructured":"Alvarez MJ, et al. Functional characterization of somatic mutations in cancer using network-based inference of protein activity. Nat Genet. 2016;48:838\u201347.","journal-title":"Nat Genet"},{"key":"643_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-7-S1-S7","volume":"7","author":"AA Margolin","year":"2006","unstructured":"Margolin AA, et al. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics. 2006;7:1\u201315.","journal-title":"BMC Bioinformatics"},{"key":"643_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/ng.3458","volume":"48","author":"MAA Castro","year":"2015","unstructured":"Castro MAA, et al. Regulators of genetic risk of breast cancer identified by integrative network analysis. Nat Genet. 2015;48:12\u201321.","journal-title":"Nat Genet"},{"key":"643_CR28","doi-asserted-by":"publisher","unstructured":"Goldman M. The UCSC Xena platform for public and private cancer genomics data visualization and interpretation. bioRxiv. 2018:1\u201339. https:\/\/doi.org\/10.1101\/326470.","DOI":"10.1101\/326470"},{"key":"643_CR29","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.1093\/nar\/27.22.4436","volume":"27","author":"N Masuda","year":"1999","unstructured":"Masuda N, Ohnishi T, Kawamoto S, Monden M, Okubo K. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples. Nucleic Acids Res. 1999;27:4436\u201343.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"643_CR30","doi-asserted-by":"publisher","first-page":"e98187","DOI":"10.1371\/journal.pone.0098187","volume":"9","author":"Jakob Hedegaard","year":"2014","unstructured":"Hedegaard J, et al. Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue. PLoS One. 2014;9:1\u201316.","journal-title":"PLoS ONE"},{"key":"643_CR31","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","volume":"9","author":"AC Garrido-castro","year":"2019","unstructured":"Garrido-castro AC, Lin NU, Polyak K. Insights into molecular Classifi cations of triple-negative Breast Cancer : improving patient selection for treatment. Cancer Discov. 2019;9:176\u201398.","journal-title":"Cancer Discov"},{"key":"643_CR32","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer. N Engl J Med. 2004;351:2817\u201326.","journal-title":"N Engl J Med"},{"key":"643_CR33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10549-008-0191-2","volume":"117","author":"MJ Van De Vijver","year":"2009","unstructured":"Van De Vijver MJ, et al. Validation of 70-gene prognosis signature in node-negative breast cancer. Breast Cancer Res Treat. 2009;117:483\u201395.","journal-title":"Breast Cancer Res Treat"},{"key":"643_CR34","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1200\/JCO.2007.14.3222","volume":"26","author":"F Cardoso","year":"2008","unstructured":"Cardoso F, et al. Clinical application of the 70-gene profile: the MINDACT trial. J Clin Oncol. 2008;26:729\u201335.","journal-title":"J Clin Oncol"},{"key":"643_CR35","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ Van Veer","year":"2002","unstructured":"Van Veer LJ, et al. Gene expression profiling predicts clinical outcomes of breast cancer. Nature. 2002;415:530\u20136.","journal-title":"Nature"},{"key":"643_CR36","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.ajpath.2017.08.002","volume":"187","author":"WB Coleman","year":"2017","unstructured":"Coleman WB, Anders CK. Discerning clinical responses in Breast Cancer based on molecular signatures. Am J Pathol. 2017;187:2199\u2013207.","journal-title":"Am J Pathol"},{"key":"643_CR37","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10549-017-4262-0","volume":"164","author":"LJMJ Delahaye","year":"2017","unstructured":"Delahaye LJMJ, et al. A breast cancer gene signature for indolent disease. Breast Cancer Res Treat. 2017;164:461\u20136.","journal-title":"Breast Cancer Res Treat"},{"key":"643_CR38","first-page":"1","volume":"3","author":"JJ Bower","year":"2017","unstructured":"Bower JJ, et al. Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells npj. Breast Cancer. 2017;3:1\u20139.","journal-title":"Breast Cancer"},{"issue":"43","key":"643_CR39","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A. Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;12:15545\u201350.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"643_CR40","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/jnci\/djr438","volume":"103","author":"C Hatzis","year":"2010","unstructured":"Hatzis C, et al. Effects of tissue handling on rna integrity and microarray measurements from resected breast cancers. J Natl Cancer Inst. 2010;103:1871\u201383.","journal-title":"J Natl Cancer Inst"},{"key":"643_CR41","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.mayocp.2012.07.023","volume":"87","author":"K Da Yu","year":"2012","unstructured":"Da Yu K, et al. Effect of large tumor size on cancer-specific mortality in node-negative breast cancer. Mayo Clin Proc. 2012;87:1171\u201380.","journal-title":"Mayo Clin Proc"},{"key":"643_CR42","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0090-3671(08)70227-1","volume":"2007","author":"T Eberlein","year":"2007","unstructured":"Eberlein T, Race J. Breast Cancer subtypes, and survival in the Carolina Breast Cancer study. Yearb Surg. 2007;2007:304\u20135.","journal-title":"Yearb Surg"},{"key":"643_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-14-177","volume":"14","author":"T Nielsen","year":"2014","unstructured":"Nielsen T, et al. Analytical validation of the PAM50-based Prosigna Breast Cancer prognostic gene signature assay and nCounter analysis system using formalin-fixed paraffin-embedded breast tumor specimens. BMC Cancer. 2014;14:1\u201314.","journal-title":"BMC Cancer"},{"key":"643_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2014.00339","volume":"4","author":"KE Royse","year":"2014","unstructured":"Royse KE, et al. Differential gene expression landscape of co-existing cervical pre-cancer lesions using RNA-seq. Front Oncol. 2014;4:1\u20139.","journal-title":"Front Oncol"},{"key":"643_CR45","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-13-2699","volume":"74","author":"Q Long","year":"2014","unstructured":"Long Q, et al. Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence. Cancer Res. 2014;74:3228\u201337.","journal-title":"Cancer Res"},{"key":"643_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.lungcan.2014.03.020","volume":"85","author":"ML Morton","year":"2014","unstructured":"Morton ML, et al. Identification of mRNAs and lincRNAs associated with lung cancer progression using next-generation RNA sequencing from laser micro-dissected archival FFPE tissue specimens. Lung Cancer. 2014;85:31\u20139.","journal-title":"Lung Cancer"},{"key":"643_CR47","doi-asserted-by":"publisher","first-page":"32990","DOI":"10.18632\/oncotarget.16518","volume":"8","author":"AS Nikitina","year":"2017","unstructured":"Nikitina AS, et al. Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients. Oncotarget. 2017;8:32990\u20133001.","journal-title":"Oncotarget"},{"key":"643_CR48","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.urolonc.2013.06.014","volume":"32","author":"X Sharron Lin","year":"2014","unstructured":"Sharron Lin X, et al. Differentiating progressive from nonprogressive T1 bladder cancer by gene expression profiling: applying RNA-sequencing analysis on archived specimens. Urol Oncol Semin Orig Investig. 2014;32:327\u201336.","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"80","key":"643_CR49","first-page":"207","volume":"352","author":"EM Van Allen","year":"2016","unstructured":"Van Allen EM, et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science. 2016;352(80):207\u201312.","journal-title":"Science"},{"key":"643_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0149743","volume":"11","author":"O Eikrem","year":"2016","unstructured":"Eikrem O, et al. Transcriptome sequencing (RNAseq) enables utilization of formalin-fixed, paraffin-embedded biopsies with clear cell renal cell carcinoma for exploration of disease biology and biomarker development. PLoS One. 2016;11:1\u201319.","journal-title":"PLoS One"},{"key":"643_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-017-3237-1","volume":"17","author":"B Jovanovi\u0107","year":"2017","unstructured":"Jovanovi\u0107 B, et al. Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue. BMC Cancer. 2017;17:1\u201314.","journal-title":"BMC Cancer"},{"key":"643_CR52","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.eururo.2014.07.045","volume":"66","author":"Y Liu","year":"2014","unstructured":"Liu Y, et al. Next-generation RNA sequencing of archival formalin-fixed paraffin-embedded urothelial bladder cancer. Eur Urol. 2014;66:982\u20136.","journal-title":"Eur Urol"},{"key":"643_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep12335","volume":"5","author":"S Graw","year":"2015","unstructured":"Graw S, et al. Robust gene expression and mutation analyses of RNA-sequencing of formalin-fixed diagnostic tumor samples. Sci Rep. 2015;5:1\u201311.","journal-title":"Sci Rep"},{"key":"643_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0170632","volume":"12","author":"A Esteve-Codina","year":"2017","unstructured":"Esteve-Codina A, et al. A comparison of RNA-Seq results from paired formalin-fixed paraffin-embedded and fresh-frozen glioblastoma tissue samples. PLoS One. 2017;12:1\u201318.","journal-title":"PLoS One"},{"key":"643_CR55","doi-asserted-by":"publisher","first-page":"e0216050","DOI":"10.1371\/journal.pone.0216050","volume":"14","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, et al. Robustness of RNA sequencing on older formalin-fixed paraffin-embedded tissue from high-grade ovarian serous adenocarcinomas. PLoS One. 2019;14:e0216050.","journal-title":"PLoS One"},{"key":"643_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0081925","volume":"8","author":"N Norton","year":"2013","unstructured":"Norton N, et al. Gene expression, single nucleotide variant and fusion transcript discovery in archival material from breast tumors. PLoS One. 2013;8:1\u201311.","journal-title":"PLoS One"},{"key":"643_CR57","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.18632\/oncotarget.14257","volume":"8","author":"R Chen","year":"2017","unstructured":"Chen R, et al. Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples. Oncotarget. 2017;8:6652\u201362.","journal-title":"Oncotarget"},{"key":"643_CR58","first-page":"1","volume":"9","author":"B Omolo","year":"2016","unstructured":"Omolo B, et al. Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer. BMC Med Genet. 2016;9:1\u201310.","journal-title":"BMC Med Genet"},{"key":"643_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-019-5849-0","volume":"20","author":"AC Picornell","year":"2019","unstructured":"Picornell AC, et al. Breast cancer PAM50 signature: correlation and concordance between RNA-Seq and digital multiplexed gene expression technologies in a triple negative breast cancer series. BMC Genomics. 2019;20:1\u201311.","journal-title":"BMC Genomics"},{"key":"643_CR60","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ygeno.2009.07.007","volume":"94","author":"L Roberts","year":"2009","unstructured":"Roberts L, et al. Identification of methods for use of formalin-fixed, paraffin-embedded tissue samples in RNA expression profiling. Genomics. 2009;94:341\u20138.","journal-title":"Genomics"},{"key":"643_CR61","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4048\/jbc.2017.20.4.393","volume":"20","author":"Y Choi","year":"2017","unstructured":"Choi Y, et al. Optimization of RNA extraction from formalin-fixed paraffin-embedded blocks for targeted next-generation sequencing. J Breast Cancer. 2017;20:393.","journal-title":"J Breast Cancer"},{"key":"643_CR62","first-page":"1","volume":"15","author":"P Li","year":"2014","unstructured":"Li P, Conley A, Zhang H, Kim HL. Whole-Transcriptome profiling of formalin-fixed, paraffin-embedded renal cell carcinoma by RNA-seq. BMC Genomics. 2014;15:1\u20139.","journal-title":"BMC Genomics"},{"issue":"3","key":"643_CR63","doi-asserted-by":"publisher","first-page":"e17830","DOI":"10.1371\/journal.pone.0017830","volume":"6","author":"Masahito Kawazu","year":"2011","unstructured":"Kawazu M, et al. Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLoS One. 2011;6:1\u201313.","journal-title":"PLoS ONE"},{"key":"643_CR64","doi-asserted-by":"publisher","first-page":"6892","DOI":"10.1093\/nar\/gkt469","volume":"41","author":"L Gaughan","year":"2013","unstructured":"Gaughan L, et al. KDM4B is a master regulator of the estrogen receptor Signalling Cascade. Nucleic Acids Res. 2013;41:6892\u2013904.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"643_CR65","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"Aaron M. Newman","year":"2019","unstructured":"Newman AM, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773\u201382.","journal-title":"Nature Biotechnology"},{"key":"643_CR66","unstructured":"Yang B, et al. An assessment of prognostic immunity markers in breast cancer. Breast Cancer. 2018;35:1\u20139."}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-019-0643-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12920-019-0643-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-019-0643-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T19:30:01Z","timestamp":1608233401000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-019-0643-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["643"],"URL":"https:\/\/doi.org\/10.1186\/s12920-019-0643-z","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"11 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Breast specimens were collected from women who underwent clinically indicated biopsies under Institutional Review Board approval from the University of Colorado (OHSU IRB# 00010989) or Kaiser Permanente Center for Health Research (OHSU IRB# 15361) and were determined by participating Institutional Review Boards to be exempt for participation consent, as all cases were de-identified to the research team at all points.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}